Search

Your search keyword '"Gadoterate Meglumine"' showing total 17 results
Start Over Descriptor "Gadoterate Meglumine" Publication Type News
17 results on '"Gadoterate Meglumine"'

1. Thermax, InterGlobe Aviation and Indian Bank to see some action today

Subjects
Gadoterate meglumine, Energy industries, Gadobutrol, Aviation, Energy industry, Aeronautics
Abstract

Oriental Rail Infrastructure has secured order worth Rs 1.43 crore from Integral Coach Factory, Chennai, Indian Railways Thermax's wholly owned subsidiary -- Thermax Babcock & Wilcox Energy Solutions (TBWES) has [...]

Published
2024

2. Zydus announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable, contrast agents in the US English

Subjects
Dotarem (Diagnostic agent), Health care industry, Rare earth metal compounds, Generic drugs, Gadoterate meglumine, Gadobutrol, Magnetic resonance imaging
Abstract

AHMEDABAD, India: Zydus Lifesciences Limited has issued the following news release: Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE [...]

Published
2024

3. Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals

Subjects
Dotarem (Diagnostic agent) -- Licensing agreements, Licensing agreements, Licensing, certification and accreditation, Health care industry, Company licensing agreement, Health care industry -- Licensing, certification and accreditation -- Licensing agreements, Generic drugs -- Licensing agreements, Gadoterate meglumine, Gadobutrol
Abstract

M2 PHARMA-September 16, 2024-Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals (C)2024 M2 COMMUNICATIONS India-based pharmaceutical company focused on manufacturing generic drugs Zydus Lifesciences Ltd. announced on Friday [...]

Published
2024

4. Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals

Subjects
Dotarem (Diagnostic agent) -- Licensing agreements, Licensing agreements, Licensing, certification and accreditation, Health care industry, Company licensing agreement, Health care industry -- Licensing, certification and accreditation -- Licensing agreements, Generic drugs -- Licensing agreements, Gadoterate meglumine, Gadobutrol
Abstract

M2 EQUITYBITES-September 16, 2024-Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk India-based pharmaceutical company focused on manufacturing generic drugs Zydus Lifesciences Ltd. announced on [...]

Published
2024

5. United States : GE Healthcare Completes Portfolio of Macrocyclic MRI Contrast Agent Clariscan (gadoterate meglumine) with U.S. FDA Approval of Clariscan in 5mL Glass Vials

Subjects
United States. Food and Drug Administration, Packaging, Drug approval, Gadoterate meglumine, Magnetic resonance imaging, Business, international
Abstract

The U.S. FDA has approved 5mL glass vial packaging for Clariscan (gadoterate meglumine), completing its packaging portfolio. Clariscan is now approved for patients aged two years and under, making the [...]

Published
2020

6. GE Healthcare Completes Portfolio of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) with U.S. FDA Approval of Clariscan in 5mL Glass Vials

Subjects
United States. Food and Drug Administration, Child health, Drug approval, Gadoterate meglumine, Magnetic resonance imaging, Business, Business, international
Abstract

M2 PRESSWIRE-December 10, 2020-: GE Healthcare Completes Portfolio of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) with U.S. FDA Approval of Clariscan in 5mL Glass Vials (C)1994-2020 M2 COMMUNICATIONS RDATE:10122020 [...]

Published
2020

7. GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) in Pre-Filled Syringes

Subjects
United States. Food and Drug Administration, Rare earth metal compounds, Syringes, Drug approval, Gadoterate meglumine, Magnetic resonance imaging, Business, Business, international
Abstract

M2 PRESSWIRE-November 25, 2020-: GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) in Pre-Filled Syringes (C)1994-2020 M2 COMMUNICATIONS RDATE:24112020 * U.S. FDA approves pre-filled [...]

Published
2020

8. GE Healthcare's Clariscan (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle

Subjects
United States. Food and Drug Administration, Bulk drugs, Pharmacy, Drugstores, Polymer industry, Drug approval, Gadoterate meglumine, Polymers, Magnetic resonance imaging, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: GE Healthcare has issued the following news release: GE Healthcare's innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic [...]

Published
2020

9. GE Healthcare's Clariscan[TM] (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle

Subjects
United States. Food and Drug Administration, Rare earth metal compounds, Pharmacy, Drugstores, Drug approval, Gadoterate meglumine, Polymers, Magnetic resonance imaging, Business, Business, international
Abstract

* US FDA approves +PLUSPAK[TM] (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan[TM] (gadoterate meglumine) * As the only polymer bottle for an MRI contrast agent, Clariscan [...]

Published
2020

10. Guerbet To Showcase the New Dose&Care(r) and other Digital Solutions with Diagnostic and Interventional Imaging Offerings at RSNA 2019

Subjects
Medical imaging equipment, Gadoterate meglumine, Medical supplies, Backup software, Contrast media, Professional associations, General interest, News, opinion and commentary
Abstract

PRINCETON: Guerbet LLC USA has issued the following press release: Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and comprehensive solutions for medical imaging, [...]

Published
2019

11. GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan (gadoterate meglumine) Injection for Intravenous Use

Subjects
United States. Food and Drug Administration, Gadoterate meglumine, Magnetic resonance imaging, Rare earth metal compounds, Physicians, Gadolinium, Contrast media, Child health, General interest, News, opinion and commentary
Abstract

CHALFONT ST GILES: GE Healthcare has issued the following press release: The U.S. Food and Drug Administration (FDA) has approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the [...]

Published
2019

12. Reports from Faculty of Medicine and University Hospital of Cologne Advance Knowledge in Life Science Research [Respiratory motion artefacts in Gd-EOB-DTPA (Primovist/Eovist) and Gd-DOTA (Dotarem)-enhanced dynamic phase liver MRI after ...]

Subjects
Preoperative care, Gadoxetate, Medical research, Gadoterate meglumine, Magnetic resonance imaging, Instructional materials, Liver, Editors, Social science research, Biological sciences, Health, Dotarem (Diagnostic agent), Eovist (Diagnostic agent)
Abstract

2020 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- A new study on Life Science Research is now available. According to news reporting [...]

Published
2020

13. Researchers from Otto-von-Guericke-University Detail New Studies and Findings in the Area of Experimental Radiology (The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes)

Subjects
Iopromide -- Research, Rare earth metal compounds, Lymphocytes, Gadolinium, Gadodiamide -- Research, Radiology, Contrast media -- Research, Magnetic resonance imaging, Ethics, Informed consent, Gadoterate meglumine, Gadoxetate, Gadobutrol, Editors, Health
Abstract

2019 DEC 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in experimental radiology. According to news reporting out of [...]

Published
2019

14. Researchers from American University of Beirut Medical Center Describe Findings in Multiple Sclerosis (Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities)

Subjects
Medical centers, Medical research, Gadoterate meglumine, Multiple sclerosis, Rare earth metal compounds, Gadolinium, Autoimmune diseases, Editors, Health
Abstract

2019 SEP 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Autoimmune Diseases and Conditions - Multiple Sclerosis have been [...]

Published
2019

15. Studies from German Cancer Research Center Yield New Data on Radiology (Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents)

Subjects
Brain, Rare earth metal compounds, Gadolinium, Gadodiamide, Cancer, Cancer research, Radiology, Gadoterate meglumine, Gadobutrol, Editors, Health
Abstract

2019 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Medical Imaging - Radiology have been published. According to [...]

Published
2019

16. New Findings from University of Turku in the Area of Gliomas Reported (Gadolinium Retention In Gliomas and Adjacent Normal Brain Tissue: Association With Tumor Contrast Enhancement and Linear/macrocyclic Agents)

Subjects
Brain, Rare earth metal compounds, Gliomas, Gadolinium, Gadodiamide, Gadoterate meglumine, Brain tumors, Surgery, Research funding, Contrast media, Tumors, Editors, Health
Abstract

2019 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Oncology - Gliomas. According to news reporting originating [...]

Published
2019

17. Studies from Technical University of Munich Describe New Findings in Multiple Sclerosis (Accuracy of Unenhanced Mri In the Detection of New Brain Lesions In Multiple Sclerosis)

Subjects
Brain damage, Gadoterate meglumine, Multiple sclerosis, Diagnostic imaging, Rare earth metal compounds, Autoimmune diseases, Gadolinium, Contrast media, Magnetic resonance imaging, Editors, Health
Abstract

2019 MAY 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Autoimmune Diseases and Conditions - Multiple Sclerosis. According [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results